InvestSMART

Pacific Edge Limited (ASX:PEB)

ALERT: Price-sensitive ASX Announcement for PEB
Current share price for PEB : $0.235 0.035 (17.50%)+
Announcement
Release
20 Feb 2026 9:25AM
Price at Release
$0.200
Full Release
download
Summary
Pacific Edge Limited requested a trading halt on their securities on 20 February 2026. This halt is due to a scheduled Contractor Advisory Committee (CAC) meeting by Novitas, Pacific Edge's Medicare Administrative Contractor. The meeting is intended to discuss the use of urine-based biomarkers in patients with microhematuria, which could impact Pacific Edge's strategic operations. The company aims to cease trading until it can assess the meeting's content and prepare a relevant market announcement. The halt is expected to last until the release of this statement or the start of normal trading on 24 February 2026.
Key Points
  • Pacific Edge Limited (PEB) has requested a trading halt.
  • The CAC meeting by Novitas could impact Pacific Edge's operations.
  • The meeting's focus is on urine-based biomarkers for microhematuria.
  • Trading halt to allow Pacific Edge to assess meeting outcomes.
  • The halt will last until a statement release or 24 February 2026 trading commencement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.